AAAAAA

   
Results: 1-14 |
Results: 14
A PHASE-III RANDOMIZED STUDY COMPARING, IN NON METASTATIC UNRESECTABLE NONSMALL CELL LUNG-CANCER (NSCLC) RESPONDING TO CHEMOTHERAPY (CT), FURTHER CT TO LOCO-REGIONAL IRRADIATION (RT)
Authors: SCULIER JP PAESMANS M BUREAU G RECLOUX P BAUMOHL J VANCUTSEM O BERCHIER MC THIRIAUX J LAFITTE JJ MOMMEN P VANHOUTTE P NINANE V KLASTERSKY J
Citation: Jp. Sculier et al., A PHASE-III RANDOMIZED STUDY COMPARING, IN NON METASTATIC UNRESECTABLE NONSMALL CELL LUNG-CANCER (NSCLC) RESPONDING TO CHEMOTHERAPY (CT), FURTHER CT TO LOCO-REGIONAL IRRADIATION (RT), Annals of oncology, 9, 1998, pp. 399-399
IS CHEMOSENSITIVITY A PREDICTIVE FACTOR FOR RADIOSENSITIVITY IN NONSMALL CELL LUNG-CANCER - LESSON FROM EUROPEAN LUNG-CANCER WORKING PARTY PHASE-III RANDOMIZED TRAIL
Authors: BAUMOHL J SCULIER JP PAESMANS M BUREAU G RECLOUX P VANCUTSEM O BERCHIER MC THIRIAUX J LAFITTE JJ MOMMEN P VANHOUTTE P NINANE V KLASTERSKY J
Citation: J. Baumohl et al., IS CHEMOSENSITIVITY A PREDICTIVE FACTOR FOR RADIOSENSITIVITY IN NONSMALL CELL LUNG-CANCER - LESSON FROM EUROPEAN LUNG-CANCER WORKING PARTY PHASE-III RANDOMIZED TRAIL, Annals of oncology, 9, 1998, pp. 402-402
RESPONSE TO CHEMOTHERAPY HAS PREDICTIVE VALUE FOR FURTHER SURVIVAL OFPATIENTS WITH ADVANCED NONSMALL CELL LUNG-CANCER - 10 YEARS EXPERIENCE OF THE EUROPEAN LUNG-CANCER WORKING PARTY
Authors: PAESMANS M SCULIER JP LIBERT P BUREAU G DABOUIS G THIRIAUX J MICHEL J VANCUTSEM O SERGYSELS R MOMMEN P KLASTERSKY J
Citation: M. Paesmans et al., RESPONSE TO CHEMOTHERAPY HAS PREDICTIVE VALUE FOR FURTHER SURVIVAL OFPATIENTS WITH ADVANCED NONSMALL CELL LUNG-CANCER - 10 YEARS EXPERIENCE OF THE EUROPEAN LUNG-CANCER WORKING PARTY, European journal of cancer, 33(14), 1997, pp. 2326-2332
THE PROGNOSTIC FACTORS FOR ADVANCED NONSM ALL CELL LUNG-CANCER - THE EXPERIENCE OF THE EUROPEAN LUNG-CANCER WORKING PARTY
Authors: SCULIER JP PAESMANS M LIBERT P BUREAU G DABOUIS G THIRIAUX J MICHEL J VANCUTSEM O SCHMERBER J GINER V BERCHIER MC MOMMEN P SERGYSELS R KLASTERSKY J
Citation: Jp. Sculier et al., THE PROGNOSTIC FACTORS FOR ADVANCED NONSM ALL CELL LUNG-CANCER - THE EXPERIENCE OF THE EUROPEAN LUNG-CANCER WORKING PARTY, Revue des maladies respiratoires, 14(6), 1997, pp. 445-449
RANDOMIZED TRIAL COMPARING INDUCTION CHEMOTHERAPY VERSUS INDUCTION CHEMOTHERAPY FOLLOWED BY MAINTENANCE CHEMOTHERAPY IN SMALL-CELL LUNG-CANCER
Authors: SCULIER JP PAESMANS M BUREAU G GINER V LECOMTE J MICHEL J BERCHIER MC VANCUTSEM O KUSTNER U KROLL F SERGYSELS R MOMMEN P KLASTERSKY J
Citation: Jp. Sculier et al., RANDOMIZED TRIAL COMPARING INDUCTION CHEMOTHERAPY VERSUS INDUCTION CHEMOTHERAPY FOLLOWED BY MAINTENANCE CHEMOTHERAPY IN SMALL-CELL LUNG-CANCER, Journal of clinical oncology, 14(8), 1996, pp. 2337-2344
PROGNOSTIC FACTORS FOR RESPONSE TO CHEMOTHERAPY CONTAINING PLATINUM DERIVATIVES IN PATIENTS WITH UNRESECTABLE NONSMALL CELL LUNG-CANCER (NSCLC)
Authors: BORGES M SCULIER JP PAESMANS M RICHEZ M BUREAU G DABOUIS G LECOMTE J MICHEL J VANCUTSEM O SCHMERBER J GINER V BERCHIER MC SERGYSELS R MOMMEN P KLASTERSKY J
Citation: M. Borges et al., PROGNOSTIC FACTORS FOR RESPONSE TO CHEMOTHERAPY CONTAINING PLATINUM DERIVATIVES IN PATIENTS WITH UNRESECTABLE NONSMALL CELL LUNG-CANCER (NSCLC), Lung cancer, 16(1), 1996, pp. 21-33
PROGNOSTIC FACTORS FOR SURVIVAL IN ADVANCED NON-SMALL-CELL LUNG-CANCER - UNIVARIATE AND MULTIVARIATE ANALYSES INCLUDING RECURSIVE PARTITIONING AND AMALGAMATION ALGORITHMS IN 1,052 PATIENTS
Authors: PAESMANS M SCULIER JP LIBERT P BUREAU G DABOUIS G THIRIAUX J MICHEL J VANCUTSEM O SERGYSELS R MOMMEN P KLASTERSKY J
Citation: M. Paesmans et al., PROGNOSTIC FACTORS FOR SURVIVAL IN ADVANCED NON-SMALL-CELL LUNG-CANCER - UNIVARIATE AND MULTIVARIATE ANALYSES INCLUDING RECURSIVE PARTITIONING AND AMALGAMATION ALGORITHMS IN 1,052 PATIENTS, Journal of clinical oncology, 13(5), 1995, pp. 1221-1230
INDUCTION CHEMOTHERAPY WITH IFOSFAMIDE, ETOPOSIDE, AND ANTHRACYCLINE FOR SMALL-CELL LUNG-CANCER - EXPERIENCE OF THE EUROPEAN LUNG-CANCER WORKING PARTY
Authors: SCULIER JP BUREAU G GINER V THIRIAUX J MICHEL J BERCHIER MC VANCUTSEM O KUSTNER U KROLL F MOMMEN P PAESMANS M KLASTERSKY J
Citation: Jp. Sculier et al., INDUCTION CHEMOTHERAPY WITH IFOSFAMIDE, ETOPOSIDE, AND ANTHRACYCLINE FOR SMALL-CELL LUNG-CANCER - EXPERIENCE OF THE EUROPEAN LUNG-CANCER WORKING PARTY, Seminars in oncology, 22(1), 1995, pp. 18-22
AZYGOS CONTINUATION OF THE VENA-CAVA-INFE RIOR - REPORT ON 3 CASES
Authors: MAIRESSE M VANCUTSEM O MAILLEUX P SPIRLET F
Citation: M. Mairesse et al., AZYGOS CONTINUATION OF THE VENA-CAVA-INFE RIOR - REPORT ON 3 CASES, Acta Clinica Belgica, 50(2), 1995, pp. 117-120
LONG-TERM SURVIVAL AFTER CHEMOTHERAPY CONTAINING PLATINUM DERIVATIVESIN PATIENTS WITH ADVANCED UNRESECTABLE NONSMALL CELL LUNG-CANCER
Authors: SCULIER JP PAESMANS M LIBERT P BUREAU G DABOUIS G THIRIAUX J MICHEL J VANCUTSEM O SCHMERBER J GINER V BERCHIER MC SERGYSELS R MOMMEN P KLASTERSKY J
Citation: Jp. Sculier et al., LONG-TERM SURVIVAL AFTER CHEMOTHERAPY CONTAINING PLATINUM DERIVATIVESIN PATIENTS WITH ADVANCED UNRESECTABLE NONSMALL CELL LUNG-CANCER, European journal of cancer, 30A(9), 1994, pp. 1342-1347
A 4-DRUG COMBINATION CHEMOTHERAPY WITH CISPLATIN, MITOMYCIN, VINDESINE AND 5-FLUOROURACIL - A REGIMEN ASSOCIATED WITH MAJOR TOXICITY IN PATIENTS WITH ADVANCED NONSMALL CELL LUNG-CANCER
Authors: KLASTERSKY J SCULIER JP RIES F DABOUIS G LIBERT P SCHMERBER J THIRIAUX J BERCHIER MC BUREAU G VANCUTSEM O TAGNON A SERGYSELS R MOMMEN P PAESMANS M
Citation: J. Klastersky et al., A 4-DRUG COMBINATION CHEMOTHERAPY WITH CISPLATIN, MITOMYCIN, VINDESINE AND 5-FLUOROURACIL - A REGIMEN ASSOCIATED WITH MAJOR TOXICITY IN PATIENTS WITH ADVANCED NONSMALL CELL LUNG-CANCER, Annals of oncology, 5(7), 1994, pp. 641-643
SMALL-CELL LUNG-CANCER - COMPARISON TO A WEEKLY CHEMOTHERAPY WITH DRUGS WITH A STANDARD CHEMOTHERAPY
Authors: SCULIER JP PAESMANS M BUREAU G DABOUIS G LIBERT P VANDERMOTEN G VANCUTSEM O BERCHIER MC RIES F MICHEL J SERGYSELS R MOMMEN P KLASTERSKY J
Citation: Jp. Sculier et al., SMALL-CELL LUNG-CANCER - COMPARISON TO A WEEKLY CHEMOTHERAPY WITH DRUGS WITH A STANDARD CHEMOTHERAPY, Revue des maladies respiratoires, 11(3), 1994, pp. 257-261
A 4-DRUG COMBINATION CHEMOTHERAPY WITH CISPLATIN, MITOMYCIN, VINDESINE AND 5-FLUOROURACIL - A REGIMEN ASSOCIATED WITH MAJOR TOXICITY IN PATIENTS WITH ADVANCED NONSMALL CELL LUNG-CANCER
Authors: KLASTERSKY J SCULIER JP RIES F DABOUIS G LIBERT P SCHMERBER J THIRIAUX J BERCHIER MC BUREAU G VANCUTSEM O TAGNON A SERGYSELS R MOMMEN P PAESMANS M
Citation: J. Klastersky et al., A 4-DRUG COMBINATION CHEMOTHERAPY WITH CISPLATIN, MITOMYCIN, VINDESINE AND 5-FLUOROURACIL - A REGIMEN ASSOCIATED WITH MAJOR TOXICITY IN PATIENTS WITH ADVANCED NONSMALL CELL LUNG-CANCER, Lung cancer, 11(5-6), 1994, pp. 373-384
MULTIPLE-DRUG WEEKLY CHEMOTHERAPY VERSUS STANDARD COMBINATION REGIMENIN SMALL-CELL LUNG-CANCER - A PHASE-III RANDOMIZED STUDY CONDUCTED BYTHE EUROPEAN LUNG-CANCER WORKING PARTY
Authors: SCULIER JP PAESMANS M BUREAU G DABOUIS G LIBERT P VANDERMOTEN G VANCUTSEM O BERCHIER MC RIES F MICHEL J SERGYSELS R MOMMEN P KLASTERSKY J
Citation: Jp. Sculier et al., MULTIPLE-DRUG WEEKLY CHEMOTHERAPY VERSUS STANDARD COMBINATION REGIMENIN SMALL-CELL LUNG-CANCER - A PHASE-III RANDOMIZED STUDY CONDUCTED BYTHE EUROPEAN LUNG-CANCER WORKING PARTY, Journal of clinical oncology, 11(10), 1993, pp. 1858-1865
Risultati: 1-14 |